BUZZ-Pharmaron's HK stock jumps most in 4-1/2 months on solid earnings estimates

Reuters07-22

** Hong Kong shares of Pharmaron Beijing rise 7.8% to HK$9.39, on track for biggest one-day pct gain since March 4

** Stock hits the highest since June 20; third biggest pct gainer on the Hang Seng Composite Index , which slips 0.1%

** Shenzhen-listed stock rises 6.5% to 21.32 yuan, highest since June 12

** Chinese laboratory and clinical development services group expects H1 net profit to jump 34%-45% Y/Y

** Nomura keeps "buy" rating, says 2Q24 remains downbeat while some improvement signs emerge

** The blue-chip CSI 300 Index eases 0.8% and the Shanghai Composite Index down 0.9%

** In Hong Kong, the healthcare index climbs 0.6%, while the Hang Seng Index slips 0.1%

** Co's Hong Kong shares down 44.9% YTD, Shenzhen stock down 27%

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment